ReShape Lifesciences OverviewReShape Lifesciences Other Income Expense Net
Other Income/Expense Net for RSLS.
Quarterly Other Income/Expense
$141814.00
↓ 96.15% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$398753.00
↓ 112.33% YoY
Trailing 12 months ending Mar 31, 2026